| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/17/2011 | US7943328 Method and system for assisting in diagnosing irritable bowel syndrome |
| 05/17/2011 | US7943327 Measuring circulating free drug in patient using differentially labeled antibodies and flow cytometry |
| 05/17/2011 | US7943326 Diagnostic assay for anti-von Willebrand Factor cleaving protease (ADAMTS13) antibodies |
| 05/17/2011 | US7943325 Diagnosis of fertility conditions using a serine protease |
| 05/17/2011 | US7943324 Endometriosis markers |
| 05/17/2011 | US7943323 by detecting whole or non-fragmented parathyroid hormone and also a large non-whole peptide fragment hormone inhibitor |
| 05/17/2011 | US7943321 Rapid, sensitive and quantitative methods for tissue and cell-based proteomics via consecutive addition of quantifiable extenders |
| 05/17/2011 | US7943319 Utility of RET mutant in diagnosis and treatment of melanoma |
| 05/17/2011 | US7943312 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides |
| 05/17/2011 | US7943307 Methods for analyzing nucleic acid sequences |
| 05/17/2011 | US7943305 High speed nucleic acid sequencing |
| 05/17/2011 | US7943304 Method and apparatus for chromosome profiling |
| 05/17/2011 | US7943302 C20ORF23 as modifier of the IGFR pathway and methods of use |
| 05/17/2011 | US7943301 DNA conformational switches as sensitive electronic sensors of analytes |
| 05/17/2011 | US7943300 Method for improved protein expression in bacteria by monitoring and modulating protein folding |
| 05/17/2011 | US7943297 Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients |
| 05/17/2011 | US7943296 Methods of screening using a natriuretic peptide receptor |
| 05/17/2011 | US7943295 Screening and therapeutic method for NSCLC targeting CDCA1-KNTC2 complex |
| 05/17/2011 | US7943294 Methods for detecting oncofetal fibronectin |
| 05/17/2011 | US7943153 Vaccines for Mycoplasma bovis and methods of use |
| 05/17/2011 | US7943137 FPRL1 ligands and use thereof |
| 05/17/2011 | US7943125 Attenuated gram negative bacteria |
| 05/17/2011 | US7943091 Chemical exposure indication device |
| 05/17/2011 | US7943090 Plastic injection-moulded part with embedded component |
| 05/17/2011 | US7943089 Electrochemical apparatus comprising working electrodes for detecting presence or quantifying an analyte in solution; redox systems |
| 05/17/2011 | US7943064 Organic species that facilitate charge transfer to or from nanostructures |
| 05/17/2011 | US7943063 Thermochromic indicator materials with controlled reversibility |
| 05/17/2011 | US7943023 Programmable multiplexed active biologic array |
| 05/17/2011 | US7943022 Analyte test strip with improved reagent deposition |
| 05/17/2011 | US7942057 Method and a system for monitoring structural changes of a fiber web |
| 05/17/2011 | CA2573257C Probe for detection and quantification of nitric oxide, and method for detecting and quantifying nitric oxide using the same |
| 05/17/2011 | CA2539187C Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor |
| 05/17/2011 | CA2440045C Method for sample identification in a mammal as well as a kit for performing this method |
| 05/17/2011 | CA2435917C Highly sensitive method for the detection of cytosine methylation patterns |
| 05/17/2011 | CA2382436C Methods for improving signal detection from an array |
| 05/12/2011 | WO2011057250A1 Reagents and methods for detecting pnh type ii white blood cells and their identification as risk factors for thrombotic disorders |
| 05/12/2011 | WO2011057229A2 Fluorescent analogs of neurotransmitters, compositions containing the same and methods of using the same |
| 05/12/2011 | WO2011057214A2 Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor |
| 05/12/2011 | WO2011057200A1 Preparing hapten-specific antibodies and their application for immunodiagnostics and research |
| 05/12/2011 | WO2011057197A2 Integrated droplet actuator for gel electrophoresis and molecular analysis |
| 05/12/2011 | WO2011057147A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 05/12/2011 | WO2011057128A1 Ex host maturation of germline stem cells |
| 05/12/2011 | WO2011057123A1 Germline stem cell banking system |
| 05/12/2011 | WO2011057107A2 Microchamber electrochemical cell having a nanoslot |
| 05/12/2011 | WO2011057078A2 Compositions and methods for detecting plectin-1 as a biomarker for cancer |
| 05/12/2011 | WO2011057063A2 Compositions and methods for quantitatively monitoring lipids |
| 05/12/2011 | WO2011057034A2 Catenae: serosal cancer stem cells |
| 05/12/2011 | WO2011057029A1 Positively charged species as binding reagents in the separation of protein aggregates from monomers |
| 05/12/2011 | WO2011057025A2 Methods and devices to enhance sensitivity and evaluate sample adequacy and reagent reactivity in rapid lateral flow immunoassays |
| 05/12/2011 | WO2011057017A1 Aqueous nanoparticle suspensions for use in drug discovery |
| 05/12/2011 | WO2011056975A2 Genetically encoded calcium indicators and methods of use |
| 05/12/2011 | WO2011056963A1 Methods and compositions for predicting survival in subjects with cancer |
| 05/12/2011 | WO2011056958A2 Detection and treatment of traumatic brain injury |
| 05/12/2011 | WO2011056936A2 Nanostructured devices including analyte detectors, and related methods |
| 05/12/2011 | WO2011056663A1 Method of treating cancer using combination of a bifunctional alkylating agent and dna repair inhibitors |
| 05/12/2011 | WO2011056655A2 Use of cell lines to determine levels of efficacy of pharmaceutical formulations |
| 05/12/2011 | WO2011056643A2 Microfluidic platform for discrete cell assay |
| 05/12/2011 | WO2011056606A1 Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis |
| 05/12/2011 | WO2011056590A1 Assays for the detection of anti-tnf drugs and autoantibodies |
| 05/12/2011 | WO2011056575A2 Covalent attachment of peptides and biological molecules to luminescent semiconductor nanocrystals |
| 05/12/2011 | WO2011056572A1 Methods of diagnosing diastolic dysfunction |
| 05/12/2011 | WO2011056489A2 Diagnostic methods for determining prognosis of non-small cell lung cancer |
| 05/12/2011 | WO2011056415A1 Methods for quantifying vitamin d metabolites by mass spectrometry |
| 05/12/2011 | WO2011056222A1 Methods of treating disorders associated with protein aggregation |
| 05/12/2011 | WO2011055987A2 Method for screening of quorum sensing inhibitors |
| 05/12/2011 | WO2011055968A2 Kit for detecting bacterial infection comprising novel monoclonal antibodies |
| 05/12/2011 | WO2011055698A1 Fish egg maturity assessment device and fish egg maturity assessment method |
| 05/12/2011 | WO2011055286A1 Apparatus for measuring a level of a specific gas in exhaled breath |
| 05/12/2011 | WO2011055250A2 System and method of monitoring breathing |
| 05/12/2011 | WO2011054992A1 Method for the chemical modification of tantalum pentoxide surfaces |
| 05/12/2011 | WO2011054961A1 System and method for detecting and quantifying active t-cells or natural killer cells |
| 05/12/2011 | WO2011054960A1 Data acquisition method for determining the total amount of haemoglobin (thb amount) in an organism or a metabolic state of an organism |
| 05/12/2011 | WO2011054900A1 Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia |
| 05/12/2011 | WO2011054893A2 Biomarkers predictive of progression of fibrosis |
| 05/12/2011 | WO2011054851A1 Novel process |
| 05/12/2011 | WO2011054829A1 NT-pro ANP AND SFlt-1 FOR THE DIFFERENTIATION BETWEEN CIRCULATORY AND ISCHEMIC EVENTS |
| 05/12/2011 | WO2011054702A1 Identification of biomarkers |
| 05/12/2011 | WO2011054601A1 Method and kit for testing various selected materials and/or surface structures for culturing cells |
| 05/12/2011 | WO2011054577A1 Sensor for detecting a component of a gas mixture |
| 05/12/2011 | WO2011054359A2 Method for early detection of cancer |
| 05/12/2011 | WO2011054112A1 Antibodies that specifically block the biological activity of kidney associated antigen 1 |
| 05/12/2011 | WO2011054030A1 Treatment of cancer involving mutated kras or braf genes |
| 05/12/2011 | WO2011054021A1 Marker combination for prostate cancer diagnosis |
| 05/12/2011 | WO2011054018A1 Process for determining air-void characteristics and acquisition unit therefor |
| 05/12/2011 | WO2011035202A3 Universal fibronectin type iii binding-domain libraries |
| 05/12/2011 | WO2011035083A9 Biomarkers for iap inhibitor compounds |
| 05/12/2011 | WO2011034907A3 Protein kinase conjugates and inhibitors |
| 05/12/2011 | WO2011027311A3 Novel tumor markers |
| 05/12/2011 | WO2011008850A9 H3k27me3 and cancer |
| 05/12/2011 | WO2011005496A3 Islet1 (isl1) and hearing loss |
| 05/12/2011 | WO2011005289A3 Methods and kits for measuring enzyme activity |
| 05/12/2011 | WO2010151878A3 Rapid bed-side measurement of neutrophil elastase activity in biological fluids |
| 05/12/2011 | WO2010150210A3 Processes and devices for determining body parameters |
| 05/12/2011 | WO2010148212A3 Short telomere length on chromosome 9p is strongly associated with breast cancer risk |
| 05/12/2011 | WO2010144908A3 Mammalian genes involved in tularemia and other infections |
| 05/12/2011 | WO2010144808A3 Identification of dsg-3 as a biomarker for the detection of metastasis in lymph nodes |
| 05/12/2011 | WO2010140824A3 Composition for diagnosis and determination of prognosis of hepatocellular carcinoma |
| 05/12/2011 | WO2010136780A8 Method to detect and sequence post translationally modified peptides |
| 05/12/2011 | WO2010127057A3 Biomarkers of therapeutic responsiveness |
| 05/12/2011 | WO2010111674A3 Methods and apparatus for single molecule sequencing using energy transfer detection |